291 related articles for article (PubMed ID: 22895794)
21. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
Fink PB; Deyo RA; Hallvik SE; Hildebran C
Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
[TBL] [Abstract][Full Text] [Related]
22. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
[TBL] [Abstract][Full Text] [Related]
23. Attitudes, Beliefs, Practices, and Concerns Among Clinicians Prescribing Opioids in a Large Academic Institution.
Ebbert JO; Philpot LM; Clements CM; Lovely JK; Nicholson WT; Jenkins SM; Lamer TJ; Gazelka HM
Pain Med; 2018 Sep; 19(9):1790-1798. PubMed ID: 29177439
[TBL] [Abstract][Full Text] [Related]
24. The effects of North Carolina's prescription drug monitoring program on the prescribing behaviors of the state's providers.
Ringwalt C; Garrettson M; Alexandridis A
J Prim Prev; 2015 Apr; 36(2):131-7. PubMed ID: 25466768
[TBL] [Abstract][Full Text] [Related]
25. Barriers to Utilization of Prescription Drug Monitoring Programs Among Prescribing Physicians and Advanced Practice Registered Nurses at Veterans Health Administration Facilities in Oregon.
Mastarone GL; Wyse JJ; Wilbur ER; Morasco BJ; Saha S; Carlson KF
Pain Med; 2020 Apr; 21(4):695-703. PubMed ID: 31722393
[TBL] [Abstract][Full Text] [Related]
26. Barriers, solutions, and effect of using pharmacogenomics data to support opioid prescribing.
Bright D; Petry N; Roath E; Reckow E; Chavour S
J Manag Care Spec Pharm; 2020 Dec; 26(12):1597-1602. PubMed ID: 33252002
[TBL] [Abstract][Full Text] [Related]
27. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
28. Variations in prescription drug monitoring program use by prescriber specialty.
Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
[TBL] [Abstract][Full Text] [Related]
29. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
[TBL] [Abstract][Full Text] [Related]
30. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
31. Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D.
Yarbrough CR
Health Serv Res; 2018 Apr; 53(2):671-689. PubMed ID: 28101955
[TBL] [Abstract][Full Text] [Related]
32. Perspectives of opioid prescribers in overdose hotspots and coldspots, Massachusetts, 2019.
Santelices C; Pustz J; Chase C; Kim JY; Stopka TJ
Subst Use Misuse; 2023; 58(8):1069-1074. PubMed ID: 37073632
[TBL] [Abstract][Full Text] [Related]
33. How Are Real-time Opioid Prescribing Cognitions by Emergency Providers Influenced by Reviewing the State Prescription Drug Monitoring Program?
Landau A; Lynch M; Callaway C; Suffoletto B
Pain Med; 2019 May; 20(5):955-960. PubMed ID: 29762757
[TBL] [Abstract][Full Text] [Related]
34. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
[TBL] [Abstract][Full Text] [Related]
35. Attributes, Attitudes, and Practices of Clinicians Concerned with Opioid Prescribing.
Razouki Z; Khokhar BA; Philpot LM; Ebbert JO
Pain Med; 2019 Oct; 20(10):1934-1941. PubMed ID: 30403814
[TBL] [Abstract][Full Text] [Related]
36. Statewide Survey of Healthcare Professionals: Management of Patients With Chronic Noncancer Pain.
Howell D; Kaplan L
J Addict Nurs; 2015; 26(2):86-92. PubMed ID: 26053081
[TBL] [Abstract][Full Text] [Related]
37. Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults.
Toce MS; Michelson KA; Hudgins JD; Hadland SE; Olson KL; Monuteaux MC; Bourgeois FT
Ann Emerg Med; 2023 Apr; 81(4):429-437. PubMed ID: 36669914
[TBL] [Abstract][Full Text] [Related]
38. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
[TBL] [Abstract][Full Text] [Related]
39. Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: A survey study.
Goodin A; Bae J; Delcher C; Brown J; Roussos-Ross D
Medicine (Baltimore); 2021 Jan; 100(1):e24268. PubMed ID: 33429837
[TBL] [Abstract][Full Text] [Related]
40. Knowledge, attitudes and practices of Canadian pediatric emergency physicians regarding short-term opioid use: a descriptive, cross-sectional survey.
Fowler M; Ali S; Gouin S; Drendel AL; Poonai N; Yaskina M; Sivakumar M; Jun E; Dong K;
CMAJ Open; 2020; 8(1):E148-E155. PubMed ID: 32184278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
